X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-28 | AAOI | Applied Optoelectronics, Inc. | Kuo David C | *** See Remarks | S - Sale | $45.06 | -12,000 | 114,636 | -9% | -$540,660 | ||||||
2026-01-13 | ABM | Abm Industries Inc /De/ | Jacobsen Rene | EVP, COO | S - Sale | $44.12 | -31,034 | 51,714 | -38% | -$1,369,319 | ||||||
2026-01-14 | ACI | Albertsons Companies, Inc. | Theilmann Michael T | EVP, CHRO | S - Sale | $17.63 | -49,000 | 289,429 | -14% | -$863,767 | ||||||
2026-02-03 | ACN | Accenture Plc | Sweet Julie Spellman | Chair, CEO | S - Sale | $242.39 | -5,500 | 21,150 | -21% | -$1,333,121 | ||||||
2026-01-26 | ACN | Accenture Plc | Burgum Melissa A | Chief Accounting Officer | S - Sale | $281.02 | -3,588 | 8,179 | -30% | -$1,008,281 | ||||||
2026-01-27 | ACN | Accenture Plc | Walsh John F | CEO-The Americas | S - Sale | $276.38 | -3,986 | 27,221 | -13% | -$1,101,644 | ||||||
2026-01-14 | ACN | Accenture Plc | Sharma Manish | Chief Strategy, Services Ofcr | S - Sale | $288.13 | -2,731 | 7,057 | -28% | -$786,871 | ||||||
| D | 2026-02-02 | ADI | Analog Devices Inc | Roche Vincent | Chair, CEO | S - Sale+OE | $306.92 | -10,000 | 179,203 | -5% | -$3,069,200 | |||||
2026-02-02 | ADPT | Adaptive Biotechnologies Corp | Robins Chad M | CEO, COB | S - Sale | $18.44 | -124,998 | 2,459,245 | -5% | -$2,304,963 | ||||||
| M | 2026-02-02 | ADPT | Adaptive Biotechnologies Corp | Robins Harlan S | Chief Scientific Officer | S - Sale | $18.68 | -42,788 | 1,179,524 | -4% | -$799,105 | |||||
| D | 2026-01-12 | ADPT | Adaptive Biotechnologies Corp | Lo Francis | Chief People Officer | S - Sale+OE | $17.73 | -79,590 | 318,478 | -20% | -$1,411,131 | |||||
2026-02-02 | AEE | Ameren Corp | Moehn Michael L | Group Pres, Utilities | S - Sale | $103.60 | -6,500 | 198,306 | -3% | -$673,400 | ||||||
| M | 2026-01-20 | AEO | American Eagle Outfitters Inc | Schottenstein Jay L | Exec COB, CEO | S - Sale | $25.57 | -1,048,579 | 13,922,572 | -7% | -$26,813,205 | |||||
2026-01-15 | AEVA | Aeva Technologies, Inc. | Sinha Saurabh | CFO | S - Sale | $20.64 | -60,000 | 627,756 | -9% | -$1,238,578 | ||||||
2026-01-09 | AEVA | Aeva Technologies, Inc. | Rezk Mina | CTO | S - Sale | $18.85 | -64,787 | 4,426,429 | -1% | -$1,221,390 | ||||||
2026-01-09 | AEVA | Aeva Technologies, Inc. | Dardashti Soroush Salehian | CEO | S - Sale | $18.85 | -64,787 | 3,651,220 | -2% | -$1,221,390 | ||||||
2026-01-29 | AGNC | Agnc Investment Corp. | Kain Gary D | Dir, Exec Chair | S - Sale | $11.91 | -700,000 | 2,717,911 | -20% | -$8,336,300 | ||||||
2026-01-28 | AGNC | Agnc Investment Corp. | Pollack Kenneth L. | EVP, GC | S - Sale | $12.11 | -50,000 | 552,297 | -8% | -$605,500 | ||||||
| D | 2026-01-13 | AI | C3.Ai, Inc. | Siebel Thomas M | Exec COB, 10% | S - Sale+OE | $13.52 | -522,175 | 2,843,938 | -16% | -$7,059,806 | |||||
2026-01-08 | AIP | Arteris, Inc. | Janac K Charles | Pres, CEO, 10% | S - Sale | $16.58 | -50,000 | 9,614,810 | -1% | -$829,155 | ||||||
| D | 2026-02-04 | AIR | Aar Corp | Flanagan Sarah Louise | Interim CFO VP Fin Ops | S - Sale+OE | $108.56 | -10,750 | 32,848 | -25% | -$1,166,992 | |||||
| D | 2026-01-09 | AIR | Aar Corp | Jessup Christopher A. | SVP-CCO | S - Sale+OE | $97.05 | -23,621 | 65,769 | -26% | -$2,292,392 | |||||
| DM | 2026-01-13 | AIR | Aar Corp | Holmes John McClain III | COB, Pres, CEO | S - Sale+OE | $99.10 | -26,749 | 237,064 | -10% | -$2,650,941 | |||||
| D | 2026-01-22 | AIR | Aar Corp | Pachapa Eric | VP-CAO, Controller | S - Sale+OE | $105.94 | -4,983 | 22,245 | -18% | -$527,882 | |||||
| D | 2026-01-12 | AIR | Aar Corp | Holmes John McClain III | COB, Pres, CEO | S - Sale+OE | $97.50 | -30,000 | 237,064 | -11% | -$2,925,030 | |||||
| D | 2026-02-03 | AIR | Aar Corp | Holmes John McClain III | COB, Pres, CEO | S - Sale+OE | $108.44 | -10,000 | 235,064 | -4% | -$1,084,363 | |||||
2026-02-05 | AIT | Applied Industrial Technologies Inc | Hoffner Warren E III | VP, General Mgr-Fluid Power | S - Sale | $288.62 | -4,000 | 53,205 | -7% | -$1,154,480 | ||||||
2026-02-04 | AIT | Applied Industrial Technologies Inc | Schrimsher Neil A | Pres, CEO | S - Sale | $285.85 | -19,207 | 130,966 | -13% | -$5,490,274 | ||||||
2026-02-05 | AIT | Applied Industrial Technologies Inc | Vasquez Jason W | VP-Sales, Marketing-USSC | S - Sale | $287.87 | -5,447 | 15,368 | -26% | -$1,568,028 | ||||||
2026-01-15 | ALHC | Alignment Healthcare, Inc. | Maroney Dawn Christine | Pres | S - Sale | $22.48 | -30,000 | 1,027,015 | -3% | -$674,451 | ||||||
2026-01-12 | ALHC | Alignment Healthcare, Inc. | Kao John E | CEO | S - Sale | $21.11 | -180,000 | 4,401,020 | -4% | -$3,799,219 | ||||||
2026-02-02 | ALL | Allstate Corp | Wilson Thomas J | COB, Pres, CEO | S - Sale | $200.71 | -16,807 | 863,358 | -2% | -$3,373,324 | ||||||
2026-01-12 | ALL | Allstate Corp | Wilson Thomas J | COB, Pres, CEO | S - Sale | $207.83 | -16,807 | 880,163 | -2% | -$3,492,917 | ||||||
2026-01-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Poulton Jeffrey V. | EVP, CFO | S - Sale | $362.87 | -2,780 | 57,522 | -5% | -$1,008,766 | ||||||
2026-01-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Greenstreet Yvonne | CEO | S - Sale | $362.87 | -9,577 | 78,818 | -11% | -$3,475,157 | ||||||
2026-01-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Garg Pushkal | EVP Chief R, D | S - Sale | $362.87 | -1,510 | 23,192 | -6% | -$547,929 | ||||||
| M | 2026-01-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | S - Sale | $367.37 | -3,800 | 21,801 | -15% | -$1,395,992 | |||||
2026-01-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Tanguler Tolga | EVP, Chief Commercial Officer | S - Sale | $362.87 | -1,510 | 29,728 | -5% | -$547,927 | ||||||
| D | 2026-01-16 | AMD | Advanced Micro Devices Inc | Hahn Ava | SVP, GC, Corporate Secretary | S - Sale+OE | $234.42 | -2,442 | 16,359 | -13% | -$572,454 | |||||
| DM | 2026-01-15 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO | S - Sale+OE | $13.59 | -138,167 | 3,379,465 | -4% | -$1,878,094 | |||||
| DM | 2026-01-15 | AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-CEO | S - Sale+OE | $13.59 | -138,188 | 3,379,398 | -4% | -$1,877,570 | |||||
2026-02-04 | AMP | Ameriprise Financial Inc | Cracchiolo James M | COB, CEO | S - Sale | $544.96 | -48,813 | 109,358 | -31% | -$26,601,190 | ||||||
| DM | 2026-01-21 | AMPX | Amprius Technologies, Inc. | Stefan Constantin Ionel | CTO | S - Sale+OE | $12.03 | -567,707 | 748,696 | -43% | -$6,830,523 | |||||
| D | 2026-01-08 | ANAB | Anaptysbio, Inc | Faga Daniel | Pres, CEO | S - Sale+OE | $44.71 | -14,281 | 479,344 | -3% | -$638,504 | |||||
| D | 2026-01-20 | ANET | Arista Networks, Inc. | Duda Kenneth | Pres, CTO | S - Sale+OE | $128.43 | -56,000 | 3,213,549 | -2% | -$7,192,212 | |||||
| M | 2026-01-22 | ANF | Abercrombie & Fitch Co /De/ | Horowitz Fran | CEO | S - Sale | $96.99 | -203,200 | 505,303 | -29% | -$19,708,347 | |||||
| M | 2026-02-04 | ANF | Abercrombie & Fitch Co /De/ | Horowitz Fran | CEO | S - Sale | $103.24 | -67,031 | 338,272 | -17% | -$6,920,168 | |||||
| M | 2026-02-02 | ANF | Abercrombie & Fitch Co /De/ | Horowitz Fran | CEO | S - Sale | $101.23 | -100,000 | 405,303 | -20% | -$10,122,766 | |||||
2026-01-14 | APGE | Apogee Therapeutics, Inc. | Henderson Michael Thomas | CEO | S - Sale | $81.11 | -20,000 | 1,192,987 | -2% | -$1,622,159 | ||||||
| D | 2026-01-07 | APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | S - Sale+OE | $77.84 | -18,700 | 212,523 | -8% | -$1,455,613 | |||||
2026-01-16 | APLD | Applied Digital Corp. | Cummins Wes | CEO; COB | S - Sale | $36.42 | -165,000 | 22,489,050 | -1% | -$6,009,300 | ||||||
2026-01-22 | APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | CEO | S - Sale | $21.77 | -27,192 | 1,600,467 | -2% | -$591,845 | ||||||
2026-02-04 | ARES | Ares Management Corp | Sagati Aghili Naseem | GC | S - Sale | $134.92 | -3,921 | 326,889 | -1% | -$529,032 | ||||||
| M | 2026-02-04 | ARLO | Arlo Technologies, Inc. | Busse Brian | GC | S - Sale | $12.41 | -47,329 | 552,850 | -8% | -$587,486 | |||||
| M | 2026-02-04 | ARLO | Arlo Technologies, Inc. | McRae Matthew Blake | CEO | S - Sale | $12.42 | -172,015 | 1,011,288 | -15% | -$2,136,923 | |||||
| D | 2026-01-09 | ARLO | Arlo Technologies, Inc. | McRae Matthew Blake | CEO | S - Sale+OE | $13.69 | -90,089 | 1,018,163 | -8% | -$1,233,255 | |||||
| D | 2026-01-09 | ARLO | Arlo Technologies, Inc. | Binder Kurtis Joseph | CFO | S - Sale+OE | $13.69 | -55,043 | 460,970 | -11% | -$753,500 | |||||
2026-02-02 | ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | S - Sale | $25.28 | -40,638 | 110,003 | -27% | -$1,027,293 | ||||||
2026-02-02 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks | S - Sale | $25.50 | -19,833 | 954,440 | -2% | -$505,710 | ||||||
2026-02-05 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $13.79 | -60,425 | 349,500 | -15% | -$833,261 | ||||||
2026-02-03 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $14.71 | -37,358 | 1,173,025 | -3% | -$549,536 | ||||||
| M | 2026-01-12 | AVPT | Avepoint, Inc. | Gong Xunkai | Exec COB | S - Sale | $13.53 | -60,000 | 14,920,668 | 0% | -$812,041 | |||||
| D | 2026-02-02 | AVT | Avnet Inc | Chan Leng Jin | SVP, CIO | S - Sale+OE | $61.53 | -9,226 | 40,776 | -18% | -$567,676 | |||||
2026-02-04 | AX | Axos Financial, Inc. | Garrabrants Gregory | Pres, CEO | S - Sale | $99.10 | -43,294 | 1,589,799 | -3% | -$4,290,392 | ||||||
| D | 2026-02-05 | AXP | American Express Co | Pickett Denise | Pres, Enterprise Shared Serv. | S - Sale+OE | $356.91 | -23,385 | 9,574 | -71% | -$8,346,340 | |||||
| D | 2026-02-05 | AXP | American Express Co | Marrs Anna | Group Pres, GMNS | S - Sale+OE | $350.01 | -27,425 | 20,394 | -57% | -$9,599,024 | |||||
| D | 2026-01-22 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | S - Sale+OE | $187.92 | -12,000 | 43,076 | -22% | -$2,255,040 | |||||
| D | 2026-01-21 | AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Officer | S - Sale+OE | $184.44 | -7,500 | 0 | -100% | -$1,383,300 | |||||
| D | 2026-02-02 | AXSM | Axsome Therapeutics, Inc. | Tabuteau Herriot | CEO, 10% | S - Sale+OE | $185.60 | -32,410 | 7,351,729 | 0% | -$6,015,296 | |||||
| D | 2026-01-28 | AYI | Acuity Inc. (De) | Holcom Karen J | SVP, CFO | S - Sale+OE | $309.23 | -4,974 | 21,825 | -19% | -$1,538,110 | |||||
| D | 2026-01-23 | AZO | Autozone Inc | Smith Richard Craig | SVP | S - Sale+OE | $3,700.00 | -5,910 | 2,627 | -69% | -$21,867,000 | |||||
| D | 2026-01-16 | AZO | Autozone Inc | Smith Richard Craig | SVP | S - Sale+OE | $3,500.00 | -3,190 | 2,627 | -55% | -$11,165,000 | |||||
2026-02-03 | AZZ | Azz Inc | Ferguson Thomas E | Pres, CEO | S - Sale | $127.29 | -25,000 | 158,182 | -14% | -$3,182,140 | ||||||
2026-02-05 | BA | Boeing Co | McKenzie Howard E | Chief Engineer, EVP, ET, T | S - Sale | $233.99 | -10,497 | 20,242 | -34% | -$2,456,150 | ||||||
2026-02-04 | BA | Boeing Co | Amuluru Uma M | EVP, CHRO | S - Sale | $236.00 | -2,731 | 11,925 | -19% | -$644,598 | ||||||
| D | 2026-02-05 | BALL | Ball Corp | Carey Nate C | VP, Controller | S - Sale+OE | $66.45 | -10,718 | 7,265 | -60% | -$712,165 | |||||
| D | 2026-02-02 | BATRK | Atlanta Braves Holdings, Inc. | Robinson Jill L. | EVP, CFO, Treasurer | S - Sale+OE | $40.00 | -20,000 | 79,460 | -20% | -$800,000 | |||||
| M | 2026-01-08 | BBIO | Bridgebio Pharma, Inc. | Kumar Neil | CEO | S - Sale | $75.54 | -80,000 | 5,462,909 | -1% | -$6,043,168 | |||||
2026-02-05 | BC | Brunswick Corp | Foulkes David M | CEO | S - Sale | $86.56 | -38,266 | 278,290 | -12% | -$3,312,305 | ||||||
| DM | 2026-01-29 | BEAM | Beam Therapeutics Inc. | Evans John M. | CEO | S - Sale+OE | $28.87 | -50,000 | 1,089,667 | -4% | -$1,443,528 | |||||
2026-01-15 | BEAM | Beam Therapeutics Inc. | Bellon Christine | GC | S - Sale | $34.61 | -18,629 | 97,038 | -16% | -$644,832 | ||||||
| M | 2026-01-20 | BHE | Benchmark Electronics Inc | Benck Jeff | CEO | S - Sale | $50.24 | -15,000 | 423,180 | -3% | -$753,576 | |||||
| D | 2026-01-13 | BIOA | Bioage Labs, Inc. | Goldstein Dov A Md | CFO | S - Sale+OE | $19.70 | -27,000 | 22,408 | -55% | -$531,828 | |||||
2026-01-13 | BIOA | Bioage Labs, Inc. | Fortney Kristen | CEO | S - Sale | $18.12 | -233,107 | 976,949 | -19% | -$4,223,036 | ||||||
2026-01-15 | BKNG | Booking Holdings Inc. | Fogel Glenn D | CEO, Pres | S - Sale | $5,181.34 | -953 | 19,615 | -5% | -$4,937,816 | ||||||
| D | 2026-01-21 | BLK | Blackrock, Inc. | Kushel J. Richard | Senior MD | S - Sale+OE | $1,125.00 | -20,000 | 141,072 | -12% | -$22,500,000 | |||||
| D | 2026-01-16 | BLK | Blackrock, Inc. | Small Martin | CFO, Senior MD | S - Sale+OE | $1,171.14 | -27,047 | 10,557 | -72% | -$31,675,813 | |||||
2026-01-09 | BOX | Box Inc | Smith Dylan C | CFO | S - Sale | $29.57 | -17,000 | 1,328,195 | -1% | -$502,656 | ||||||
| D | 2026-02-02 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $93.49 | -160,901 | 1,625,414 | -9% | -$15,043,394 | |||||
2026-01-23 | BTGO | Bitgo Holdings, Inc. | Horowitz Jeff Peter | Chief Compliance Officer | S - Sale | $16.74 | -116,007 | 311,118 | -27% | -$1,941,957 | ||||||
2026-01-23 | BTGO | Bitgo Holdings, Inc. | Fang Chen | Chief Revenue Officer | S - Sale | $16.74 | -250,000 | 1,233,491 | -17% | -$4,185,000 | ||||||
2026-01-23 | BTGO | Bitgo Holdings, Inc. | Reginelli Edward | CFO | S - Sale | $16.74 | -45,000 | 539,000 | -8% | -$753,300 | ||||||
2026-01-21 | BWMN | Bowman Consulting Group Ltd. | Bowman Gary | CEO, 10% | S - Sale | $35.37 | -20,000 | 2,248,281 | -1% | -$707,400 | ||||||
| DM | 2026-01-30 | CACC | Credit Acceptance Corp | Booth Kenneth | Exec Board Member | S - Sale+OE | $504.00 | -8,000 | 28,051 | -22% | -$4,032,000 | |||||
| D | 2026-01-30 | CACC | Credit Acceptance Corp | Rummler Wendy A | Chief People Officer | S - Sale+OE | $493.44 | -5,236 | 24,617 | -18% | -$2,583,631 | |||||
| D | 2026-02-02 | CACC | Credit Acceptance Corp | Rummler Wendy A | Chief People Officer | S - Sale+OE | $509.20 | -2,890 | 24,617 | -11% | -$1,471,594 | |||||
| D | 2026-02-02 | CAT | Caterpillar Inc | Johnson Denise C | Group Pres | S - Sale+OE | $681.08 | -39,138 | 43,350 | -47% | -$26,655,960 | |||||
| D | 2026-02-02 | CAT | Caterpillar Inc | Fassino Anthony D. | Group Pres | S - Sale+OE | $680.45 | -10,671 | 42,650 | -20% | -$7,261,082 | |||||
| D | 2026-02-04 | CAT | Caterpillar Inc | De Lange Bob | Group Pres | S - Sale+OE | $704.97 | -16,070 | 79,953 | -17% | -$11,328,811 | |||||
| D | 2026-02-02 | CAT | Caterpillar Inc | De Lange Bob | Group Pres | S - Sale+OE | $682.99 | -15,977 | 79,953 | -17% | -$10,912,131 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |